Banner
Welcome to

Developmental Medicine

Share

Research

In Developmental Medicine, we remain committed to advancing care through rigorous clinical and scientific research.

In collaboration with Albert Einstein College of Medicine’s Children's Evaluation and Rehabilitation Center (CERC), our team has launched an array of research initiatives, many focused on investigating the underlying causes of autism, learning disabilities, cerebral palsy and other developmental disabilities.

These efforts have a clear, unswerving goal: to find cures and more effective treatments for these conditions by identifying their genetic, neurologic, physiologic and environmental etiologies. Once we understand these causes, the medical community will be empowered to take on these disabilities at the source, rather than treat the symptoms.

Beyond finding the bases of these problems, our research aims to evaluate and increase the efficacy of currently used treatments. We’re also actively involved in studies on physical rehabilitation, speech pathology, hearing and language development, social and behavioral adjustment, learning disabilities and more.

The Rose F. Kennedy Intellectual and Developmental Disabilities Research Center (IDDRC)

Specializing in intellectual and developmental disabilities in children and adolescents, the Rose F. Kennedy IDDRC serves as our central hub of research labs and patient clinics. For more than four decades, the IDDRC has been a vanguard of new research on brain development and function. Bridging the gap between academic research and clinical care, the scientists at IDDRC contribute landmark research on autism, Rett syndrome, Fragile X syndrome, Niemann-Pick C, seizure disorders, deafness, communication disorders and more.

The Rose F. Kennedy University Center for Excellence in Developmental Disabilities (UCEDD)

The Rose F. Kennedy UCEDD is dedicated to improving the lives of those with developmental disabilities. Along with offering direct services and providing interdisciplinary training, the UCEDD’s research focuses on creating, implementing and evaluating family-oriented strategies. By sharing this applied research openly with aligned agencies, Einstein’s UCEDD aims to enhance access to cutting-edge care for underserved communities.

Meet Sophie Molhom, director for research at CERC

Active Clinical Trials

Trial Description
Disease / Condition
Principal Investigator
Contact
Trial DescriptionCannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD) - Phase 2, 12-week double-blind, randomized, placebo-controlled trialNCT03202303
Disease/ConditionAutism Spectrum Disorder
Principal InvestigatorEric Hollander
Trial DescriptionNeurodevelopmental Outcome of Normoglycemic Versus Hypoglycemic Neonates at Risk for Hypoglycemia NCT04875624
Disease/ConditionNeonatal Hypoglycemia
Neurodevelopmental Disorders
Principal InvestigatorMariam Susan Latuga
View all Clinical Trials